Blister Packaging Trumps Bottles For Patient Compliance, Study Shows
Patients taking medication packaged in a blister card sleeve rather than in a traditional bottle are more likely to take the prescribed dosage at the proper time, a study conducted by researchers from Ohio State University and the University of Arizona suggests.
“Packaging can assist patients with compliance,” says Renard Jackson, executive vice-president of sales and business development at Cardinal Health (Dublin, OH), a manufacturer of blister cards. “We see evidence of it in products like birth control pills that are packaged in compliance-prompting packaging versus pharmacy-style brown bottles.”
The purpose of the study was to determine whether or not a compliance-prompting package could improve patient adherence to a drug regimen for a chronic disease. The disease state studied was hypertension and the drug used was lisinopril. The 88 study participants were divided randomly into two groups: one group was provided with the drug in a bottle package and the other with the product in a blister card, in which a 28-day supply was set up in a four-week regimen. The prompting feature on the blister package was a day label that the patient placed on the top of the card when the first dose was ingested.
According to the two-year long study, 14% more of the patients using the blister card packaging refilled their prescriptions on time than did those using the bottle packaging. More important, 48% of the subjects in the blister-pack group lowered their diastolic blood pressure after 12 months, as opposed to only 18% of the participants using bottled product. A few patients, however, complained that the blister packaging was difficult to open.
“As the federal government develops policies for new prescription drug benefits for older adults, there is a need to consider how these medications are distributed,” said Phillip Schneider, the study’s lead author and a clinical professor of pharmacy at Ohio State University. “Although blister packs are slightly more expensive than a bottle, people often forget to take their bottled medications, or get confused on how to take them properly. Offering long-term medication in this type of packaging could ultimately save millions of dollars.”
–George Koroneos
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.